Literature DB >> 1864207

Smoking, the oral contraceptive pill, and Crohn's disease.

A J Wakefield1, A M Sawyerr, M Hudson, A P Dhillon, R E Pounder.   

Abstract

Both cigarette smoking and the oral contraceptive pill have been implicated as aggravating factors in Crohn's disease. Based upon the recent demonstration of multifocal gastrointestinal infarction in Crohn's disease, a possible pathogenic mechanism for this condition, we propose how smoking and the oral contraceptive pill may potentiate a tendency for focal thrombosis and hence exacerbate the activity of Crohn's disease.

Entities:  

Keywords:  Behavior; Biology; Blood Coagulation Effects; Contraception; Contraceptive Methods--side effects; Family Planning; Gastrointestinal Effects--etiology; Hematological Effects; Hemic System; Oral Contraceptives--side effects; Physiology; Smoking--side effects

Mesh：

Substances：

Year:  1991        PMID： 1864207     DOI： 10.1007/bf01297463

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  46 in total

1.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.

Authors:  C Tysk; E Lindberg; G Järnerot; B Flodérus-Myrhed
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

2.  Smoking and sugar intake are separate but interactive risk factors in Crohn's disease.

Authors:  B Katschinski; R F Logan; M Edmond; M J Langman
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

Review 3.  Prostaglandin E1 and arterial occlusive disease: pharmacological considerations.

Authors:  T Simmet; B A Peskar
Journal:  Eur J Clin Invest       Date:  1988-12       Impact factor: 4.686

4.  Should patients with inflammatory bowel disease smoke?

Authors:  G Holdstock; D Savage; M Harman; R Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04

5.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity.

Authors:  R L Edwards; J B Levine; R Green; M Duffy; E Mathews; W Brande; F R Rickles
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

7.  The effects of nicotine on PGI2 production by rat aortic endothelium.

Authors:  H A Bull; R M Pittilo; D J Blow; C M Blow; P M Rowles; N Woolf; S J Machin
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

8.  Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases.

Authors:  S Bonfils; P Hervoir; J Girodet; Y Le Quintrec; J P Bader; J Gastard
Journal:  Am J Dig Dis       Date:  1977-05

9.  Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.

Authors:  R L Nachman; K A Hajjar; R L Silverstein; C A Dinarello
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.

Authors:  J D Vassalli; J M Dayer; A Wohlwend; D Belin
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307
View more
  10 in total

1.  Remodeling of vascular wall in Crohn's disease.

Authors:  Y Funayama; I Sasaki; H Naito; K Fukushima; S Matsuno; T Masuda
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

3.  A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey.

Authors:  Serif Yilmaz; Kadim Bayan; Yekta Tüzün; Sabri Batun; Abdullah Altintaş
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

4.  Oral contraceptives, reproductive factors and risk of inflammatory bowel disease.

Authors:  Hamed Khalili; Leslie M Higuchi; Ashwin N Ananthakrishnan; James M Richter; Diane Feskanich; Charles S Fuchs; Andrew T Chan
Journal:  Gut       Date:  2012-05-22       Impact factor: 23.059

5.  Anti-cardiolipin antibodies in patients with inflammatory bowel disease.

Authors:  B W Aichbichler; W Petritsch; G A Reicht; H H Wenzl; A J Eherer; T A Hinterleitner; P Auer-Grumbach; G J Krejs
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

6.  Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain?

Authors:  Ellen S Pierce
Journal:  Gut Pathog       Date:  2010-12-17       Impact factor: 4.181

7.  Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study.

Authors:  J Cosnes; F Carbonnel; F Carrat; L Beaugerie; J P Gendre
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 8.  Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease?

Authors:  Ellen S Pierce
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

Review 9.  Severe thrombotic complications in a postpartum patient with active Crohn's disease resulting in ischemic spinal cord injury.

Authors:  W B Slot; V van Kasteel; E G Coerkamp; P J Seelen; S D van der Werf
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

10.  The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases.

Authors:  Santosh Sanagapalli; Yanna Ko; Viraj Kariyawasam; Siew C Ng; Whitney Tang; Hithanadura Janaka de Silva; Minhu Chen; Kaichun Wu; Satimai Aniwan; Ka Kei Ng; David Ong; Qin Ouyang; Ida Hilmi; Marcellus Simadibrata; Pises Pisespongsa; Saranya Gopikrishna; Rupert W Leong
Journal:  Intest Res       Date:  2018-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.